about
RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiencyHuman X-box-binding protein 1 is required for the transcription of a subset of human class II major histocompatibility genes and forms a heterodimer with c-fosA functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-YFunction of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-YAnti-endothelial cell antibodies: detection and characterization in sera from patients with autoimmune hypoparathyroidism.Role of autoimmunity in dilated cardiomyopathyDeterminants of the B-cell response against a transgenic autoantigenCloning of the major histocompatibility complex class II promoter binding protein affected in a hereditary defect in class II gene regulationThe role of an autoantigen, histidyl-tRNA synthetase, in the induction and maintenance of autoimmunityHLA antigens in idiopathic dilated cardiomyopathy.Unlike thyrotropin, thyroid-stimulating antibodies do not activate phospholipase C in human thyroid slices.Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes.Autoimmune enteropathy and colitis: is there a generalised autoimmune gut disorder?Autoimmune enteropathy in children and adults.The MHC class II E beta promoter: a complex arrangement of positive and negative elements determines B cell and interferon-gamma (IFN-gamma) regulated expression.Duke-Elder Lecture: new concepts on the role of autoimmunity in the pathogenesis of uveitis.In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferonCharacterization of a cis-acting regulatory element which silences expression of the class II-A beta gene in epithelium.Selective abrogation of major histocompatibility complex class II expression on extrahematopoietic cells in mice lacking promoter IV of the class II transactivator gene.Two DNA-binding proteins discriminate between the promoters of different members of the major histocompatibility complex class II multigene family.Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression.Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.Novel considerations on the antibody/autoantigen system in type I (insulin-dependent) diabetes mellitus.Autologous CD4 T-cell responses to ectopic class II major histocompatibility complex antigen-expressing single-cell islet cells: an in vitro insight into the pathogenesis of lymphocytic insulitis in nonobese diabetic miceTransfection of genes for cell surface products involved in antigen presentation--applications to the understanding of autoimmunity.Regulation of the local immune response by retinal cells.Hormonal support of lacrimal function, primary lacrimal deficiency, autoimmunity, and peripheral tolerance in the lacrimal gland.Etiologic factors and pathogenetic aspects of organ-specific autoimmune diseases. Essential role of autoreactive T cells and lymphokine network in the activation of effector systems responsible for tissue lesions.Mutational analysis of the DRA promoter: cis-acting sequences and trans-acting factors.Anti-calreticulin antibodies and calreticulin in sera of patients diagnosed with dilated or hypertrophic cardiomyopathy.Immunochemical and molecular properties of antibodies exhibiting binding properties to glutamic acid-tyrosine homopolymer and to self antigens.B-cell factor 1 is required for optimal expression of the DRA promoter in B cells.Immune mechanisms in autoimmune ocular disease.Ets-1 activates the DRA promoter in B cells.Gamma-interferon induces differential expression of HLA-DR, -DP and -DQ in human ciliary epithelial cells.In vivo modulation of CD1 and MHC class II expression by sheep afferent lymph dendritic cells. Comparison of primary and secondary immune responsesNon-polarized cell surface expression of HLA-A,B,C and HLA-DR antigens in Graves' thyroid follicle cells.Induction of HLA-DR expression on human myoblasts with interferon-gamma.Analysis of RNA transcripts for HLA class II genes in human small intestinal biopsies.The expression and regulation of class II antigens in normal and inflammatory bowel disease peripheral blood monocytes and intestinal epithelium.
P2860
Q24315739-B70DF980-9597-40F1-9A26-BB69E0F76FE8Q24318380-57EB2907-147F-403B-BFA6-17DB0E944E7AQ24554232-C749BC47-9072-4042-9F63-B06A039976A1Q24562002-0EC1F776-A4C4-424F-8803-626614D87D2DQ33578829-F4958AF6-E571-42E9-8744-6DAFF523B78EQ33614482-94C595DF-7167-4005-87E3-2B8E21F9146FQ33814684-E349026C-3C1E-479D-BEF9-EFEE02E5B57DQ33867492-54418F48-D730-4425-811C-D01AB01AEF9EQ33927166-B21AAC2E-D674-46BE-86C0-8245C3734B04Q34016626-DA59E1BA-B863-4665-994B-C58609C37BA8Q34187742-ED7C64DF-EBA4-4821-8F3E-6C5B14D1FA35Q34275894-6DE77D04-960D-4EDB-BB6A-933A9A9E8251Q34394963-69E990B3-43A7-4AA5-87E1-07B40EFE94A0Q34955595-9957AF97-5B97-4234-B2EC-5C9CF1B5A59BQ35016153-4898CD0A-1019-4F02-8ED5-E42466F54A58Q35179369-CF2F7DC5-35E9-46C1-88FC-681511CD7433Q36353914-000B5A13-39C3-4502-81A6-AFDB4DD78BB6Q36363437-5451869B-2FED-4815-A46E-EB553A45A2EEQ36369564-9BDA4C62-A96A-4005-A24F-5996A8F18794Q36720139-B76A0ED5-4352-49B7-8E8E-52F24FEF793FQ36839586-0B22AFD3-5173-4026-9E50-3BBE8657AE9BQ37051232-F3037990-E170-41F7-97C9-13BAB0CBF209Q37421850-97E44975-5796-4233-990B-F56CE4CB56DCQ37726181-A9782BD9-A79F-4A96-9DE9-6B0826991578Q37835886-F974959A-4FD3-445D-8EDB-2C67CCFC8DBAQ37946773-B62181A8-15F8-403D-A06F-0A2A7BA78D44Q38028575-884F6259-A99A-422B-A53E-226BF30513B4Q38219241-086B86DD-C1A6-4161-9B9E-63CAE21F34E5Q38342198-E23486AC-CC80-4F26-8A36-5849FE75E5F6Q39334546-84289A21-D00B-44B6-9299-F7BD38DB8C64Q39574530-F4A5E039-F0E8-4FBB-82C9-D12FF65A678BQ40654813-3FAFCFE1-874A-46CE-A2F5-BA8A43069A51Q41423569-4BA8CCB9-2D6E-43C8-96BA-7FF96C28BDCDQ41431603-CC919D0B-970D-4A46-8053-019C99968FE1Q41703222-DE9C56B8-D27F-48E0-BAAA-01063B23553EQ42160051-ADFFFBDE-7D5E-45FA-916D-E77E363534E8Q42468666-B0472445-9CF2-45FF-9E1A-5CA9BC6392D2Q42774282-3F653F95-8A21-40FB-B06A-8099B134AE6DQ43187569-E0D81AA7-7141-4885-A53D-7CE809244194Q43456236-E727AAC7-4B9E-48E2-ACAA-6E9164217E71
P2860
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Organ-specific autoimmunity: a 1986 overview.
@en
Organ-specific autoimmunity: a 1986 overview.
@nl
type
label
Organ-specific autoimmunity: a 1986 overview.
@en
Organ-specific autoimmunity: a 1986 overview.
@nl
prefLabel
Organ-specific autoimmunity: a 1986 overview.
@en
Organ-specific autoimmunity: a 1986 overview.
@nl
P2093
P2860
P1476
Organ-specific autoimmunity: a 1986 overview.
@en
P2093
P2860
P304
P356
10.1111/J.1600-065X.1986.TB01168.X
P577
1986-12-01T00:00:00Z